首页> 外国专利> TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED MRNA ENCODING CFTR

TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED MRNA ENCODING CFTR

机译:通过递送编码CFTR的雾化mRNA治疗囊性纤维化

摘要

The present invention provides, among other things, an improved method of treating cystic fibrosis (CF) in a human subject. The method comprises administering a composition comprising an mRNA encoding a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein at a concentration of 0.5 mg/mL or greater to a human subject via nebulization. The composition is aerosolized using a nebulizer and a nominal dose of the mRNA is administered to the human subject via the nebulizer over a period of time, typically at least 30 minutes, at a suitable nebulization rate, e.g., at least 0.2 mL/minute.
机译:除此之外,本发明提供了一种治疗人类受试者囊性纤维化(CF)的改进方法。 该方法包括施用包含编码囊性纤维化跨膜电导调节剂(CFTR)蛋白的mRNA的组合物,通过雾化浓度为0.5mg / ml或更高于人对象。 该组合物使用雾化器雾化,并且通过雾化器在一段时间内通过雾化器给予人对象的标称剂量,通常至少30分钟,以合适的雾化速率,例如至少0.2ml /分钟。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号